₹546.85
▼ -2.2 -0.40%
17 Jul 2026
NSE Listed
Krsnaa Diagnostics Ltd. (KRSNAA)
Volume: 31,545Avg Vol 1W: 42,115.6Avg Vol 1M: 52,041.352W Range:₹515₹894.4
Key Ratios
Checked 17h agoMarket Cap₹1,769 Cr
Current Price₹546.85
Previous Close₹549.05
High / Low (52w)₹894.4 / ₹515
Volume31,545
Avg Vol (1W)42,115.6
Avg Vol (1M)52,041.3
Stock P/E30.62
Book Value₹274.65
Dividend Yield—
ROE9.7%
ROA—
Revenue (TTM)₹743 Cr
Revenue Growth—
Profit Margin—
Total Debt₹19 Cr
Shares Outstanding—
Face Value₹5
EPS (TTM)₹25.65
P/B2.86
Debt / Equity0.21
50 DMA₹548.31
200 DMA₹659.76
Day change-0.40%
Price Chart
₹546.85▼ 34.49% · 1Y
2025-07-162026-07-15
20-day avg volume: 52K shares
Pros
- Company is almost debt-free.
Cons
- Revenue fell 59% YoY.
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹170 Cr | ₹186 Cr | ₹175 Cr | ₹186 Cr | ₹193 Cr | ₹206 Cr | ₹181 Cr | ₹193 Cr |
| EBITDA | ₹29 Cr | ₹32 Cr | ₹32 Cr | ₹35 Cr | ₹34 Cr | ₹40 Cr | ₹28 Cr | ₹64 Cr |
| Net Profit | ₹18 Cr | ₹20 Cr | ₹19 Cr | ₹21 Cr | ₹21 Cr | ₹24 Cr | ₹15 Cr | ₹42 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | ₹271 Cr | ₹661 Cr | ₹470 Cr | ₹507 Cr | ₹636 Cr | ₹743 Cr |
| EBITDA | ₹-134 Cr | ₹321 Cr | ₹105 Cr | ₹88 Cr | ₹86 Cr | ₹127 Cr |
| Net Profit | ₹-112 Cr | ₹185 Cr | ₹68 Cr | ₹62 Cr | ₹57 Cr | ₹78 Cr |
| EPS | -216.94 | 12.25 | 22.88 | 19.29 | 17.31 | 23.56 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹630 Cr | ₹609 Cr | ₹876 Cr | ₹910 Cr | ₹1,172 Cr | ₹1,282 Cr |
| Total Liabilities | ₹827 Cr | ₹377 Cr | ₹192 Cr | ₹171 Cr | ₹362 Cr | ₹399 Cr |
| Equity | ₹-197 Cr | ₹232 Cr | ₹684 Cr | ₹739 Cr | ₹810 Cr | ₹883 Cr |
| Total Debt | ₹123 Cr | ₹153 Cr | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹126 Cr | ₹135 Cr | ₹89 Cr | ₹43 Cr | ₹107 Cr |
| Investing | ₹-67 Cr | ₹-241 Cr | ₹-109 Cr | ₹-129 Cr | ₹-100 Cr |
| Financing | ₹20 Cr | ₹176 Cr | ₹-33 Cr | ₹84 Cr | ₹14 Cr |
| Free Cash Flow | ₹126 Cr | ₹135 Cr | ₹89 Cr | ₹43 Cr | ₹107 Cr |
Shareholding
Promoter 27.11% Institutions 17.8% Public 55.08%
Efficiency & Working Capital
ROCE10.4%
Interest Coverage5.2
Dividend Payout—
Debtor Days141 d
Inventory Days15 d
Payable Days49 d
Cash Conversion Cycle107 d
Working Capital Days156 d
Shareholding Details
As of 2026-03-31
Promoter27.1%
FII3.9%
DII13.9%
Institutions17.8%
Public55.1%
Promoter Pledge0%
No. of Shareholders53,022
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.8% | 27.8% | 27% | 27% | 27.2% | 27.2% | 27.2% | 27.2% | 27.1% | 27.1% | 27.1% | 27.1% |
| FIIs | 5.7% | 3.7% | 3.4% | 3.3% | 3.3% | 3.6% | 4% | 3.6% | 3.4% | 3.7% | 4.2% | 3.9% |
| DIIs | 19.8% | 18.7% | 16.3% | 15.4% | 15.3% | 15.9% | 14.5% | 14.3% | 14.2% | 15% | 13.9% | 13.9% |
| Public | 46.7% | 49.8% | 53.2% | 54.3% | 54.2% | 53.3% | 54.3% | 54.9% | 55.2% | 54.3% | 54.9% | 55.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 62,257 | 60,665 | 57,232 | 56,458 | 55,914 | 53,519 | 52,799 | 53,559 | 54,262 | 52,117 | 52,380 | 53,022 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Rajendra Khivraj Mutha | Shareholding of Promoter and Promoter Group | 24.8% | 80,29,920 |
| Phi Capital Trust - Phi Capital Growth Fund - I | Public Shareholding | 15.4% | 49,84,967 |
| Tata Mutual Fund - Tata Small Cap Fund | Public Shareholding | 8% | 26,08,076 |
| Krsna Diagnostics (mumbai) Private Limited | Shareholding of Promoter and Promoter Group | 2.4% | 7,65,685 |
| Amicorp Capital (mauritius) Limited | Public Shareholding | 2.2% | 7,06,035 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 2.1% | 6,64,743 |
| Bandhan Bse Healthcare Index Fund | Public Shareholding | 2% | 6,41,189 |
| Medimaze Solutions Private Limited | Public Shareholding | 1% | 3,33,186 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Rajendra Khivraj Mutha | 0 | 0% | 2026-03-31 |
| Krsna Diagnostics (mumbai) Private Limited | 0 | 0% | 2026-03-31 |
| Tata Mutual Fund - Tata Small Cap Fund | 0 | 0% | 2026-03-31 |
| Bandhan Bse Healthcare Index Fund | 0 | 0% | 2026-03-31 |
| Hdfc Life Insurance Company Limited | 0 | 0% | 2026-03-31 |
| Amicorp Capital (mauritius) Limited | 0 | 0% | 2026-03-31 |
| Phi Capital Trust - Phi Capital Growth Fund - I | 0 | 0% | 2026-03-31 |
| Medimaze Solutions Private Limited | 0 | 0% | 2026-03-31 |
| Rajendra Khivraj Mutha | 0 | 0% | 2025-12-31 |
| Krsna Diagnostics (mumbai) Private Limited | 0 | 0% | 2025-12-31 |
| Tata Mutual Fund - Tata Small Cap Fund | 0 | 0% | 2025-12-31 |
| Bandhan Small Cap Fund | 0 | 0% | 2025-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Rajendra Mutha | Chairman / Executive Director / WTD | 2025 |
| Yash Mutha | Executive Director & MD | 2025 |
| Prem Pradeep | Non Executive Director / Nominee | 2025 |
| Chetan Desai | Independent Non Exe. Director | 2025 |
| Adesh Gupta | Independent Non Exe. Director | 2025 |
| Mr. Sujoy Sudipta Bose | Company Sec. & Compli. Officer | 2025 |
| Raju Venkatraman | Additional Director | 2025 |
| Jessie Paul | Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| providing Radiology and Pathology s | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹5 | 147 | 16 | 16 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-12 | ₹2.75 (55%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 76 | 0 | 0 | 11 | 0 | 87 |
| 2025 | 35 | 0 | 0 | 0 | 0 | 35 |
| 2025 | 0 | 0 | 0 | 11 | 0 | 11 |
Insider / Designated-Person Trades
13 recent disclosure(s)
Krsna Diagnostics Mumbai Private LimitedAcquisition · 22,929
KRSNA DIAGNOSTICS MUMBAI PRIVATE LIMITEDAcquisition · 45,000
Krsna Diagnostics Mumbai Private LimitedAcquisition · 1,30,000
Phi Capital Trust û Phi Capital Growth Fund û 1Acquisition · 7,700
Phi Capital Trust û Phi Capital Growth Fund û 1Acquisition · 10,000
Phi Capital Trust û Phi Capital Growth Fund û 1Acquisition · 10,000
Substantial Acquisitions (SAST)
2 disclosure(s)
Market27/12/2024 · 22,929
Market23/10/2023 · 62,682
Company Information
Incorporated2010
ChairmanRajendra Mutha
AuditorMSKA & Associates/Kirtane & Pandit LLP
Investor Email[email protected]
📍 S.No. 243/A Hissa No.6 Near, Chinchwad Station Chinchwad, Pune, Maharashtra, 411019
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search